🇺🇸 FDA
Pipeline program

Rabeprazole Sodium 10mg

YJ26-101

Phase 1 small_molecule completed

Quick answer

Rabeprazole Sodium 10mg for Gastroesophageal Reflux Disease is a Phase 1 program (small_molecule) at Yung NA with 1 ClinicalTrials.gov record(s).

Program details

Company
Yung NA
Indication
Gastroesophageal Reflux Disease
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials